# Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence

**Authors:** Natalia Kurhaluk, Renata Kołodziejska, Zbigniew Mazur, Oleksandr Lukash, Oleksandr Yakovenko, Halina Tkaczenko

PMC · DOI: 10.3390/ijms27042066 · International Journal of Molecular Sciences · 2026-02-23

## TL;DR

This review explores how functional foods can influence epigenetic processes during adolescence to improve metabolic health and prevent diseases like obesity and diabetes.

## Contribution

The paper synthesizes recent evidence on how diet-derived bioactives modulate epigenetic mechanisms affecting metabolic health in adolescents.

## Key findings

- Dietary bioactives influence DNA methylation, histone modifications, and microRNA networks in metabolic pathways.
- Short-chain fatty acids from gut microbiota act as histone deacetylase inhibitors, affecting epigenetic remodeling in adipose tissue.
- Polyphenols and omega-3 fatty acids show potential in counteracting metabolic risks through epigenetic modulation.

## Abstract

Adolescence represents a critical window of metabolic plasticity, during which profound hormonal, neurobiological, and physiological remodelling increases susceptibility to nutritional exposures. In parallel with the rising prevalence of obesity, insulin resistance, metabolic syndrome, and non-alcoholic fatty liver disease among young people, there is growing interest in the potential for functional food components to modulate epigenetic pathways that govern metabolic programming. This narrative review synthesises current evidence (2015–2025) from PubMed, Scopus, Web of Science, and Embase to elucidate how diet-derived bioactive compounds influence epigenetic regulation relevant to adipogenesis, appetite control, insulin signalling, and lipid homeostasis during adolescence. Particular emphasis is placed on molecular mechanisms, including DNA methylation changes in genes regulating adipocyte differentiation, hypothalamic neuropeptide expression, and pancreatic β-cell function; histone modifications, such as acetylation and methylation events that remodel chromatin accessibility in metabolic tissues; and modulation of microRNA networks implicated in lipid metabolism, inflammatory signalling, and insulin secretion. Furthermore, the review examines the interplay between diet, the gut microbiota, and the epigenome, highlighting the role of microbially derived short-chain fatty acids (SCFAs) as endogenous histone deacetylase inhibitors and mediators of epigenetic remodelling in adipose tissue. By linking these mechanisms to specific functional food components, including polyphenols, long-chain omega-3 fatty acids, fermentable dietary fibre, and other bioactive molecules, we demonstrate how nutritional signals can counteract maladaptive metabolic trajectories and potentially reduce the intergenerational transmission of metabolic risk. A deeper understanding of these epigenetic effects provides the foundation for developing personalised nutrition strategies aimed at preventing metabolic disorders from emerging during adolescence and beyond.

## Linked entities

- **Diseases:** obesity (MONDO:0011122), metabolic syndrome (MONDO:0000816), non-alcoholic fatty liver disease (MONDO:0013209)

## Full-text entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MLXIPL (MLX interacting protein like) [NCBI Gene 51085] {aka CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH, bHLHd14}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, APOA5 (apolipoprotein A5) [NCBI Gene 116519] {aka APOAV, RAP3}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, MS4A2 (membrane spanning 4-domains A2) [NCBI Gene 2206] {aka APY, ATOPY, FCER1B, FCERI, IGEL, IGER}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, MAT1A (methionine adenosyltransferase 1A) [NCBI Gene 4143] {aka MAT, MATA1, SAMS, SAMS1}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, TRAP [NCBI Gene 100187907], RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, HDAC3 (histone deacetylase 3) [NCBI Gene 8841] {aka HD3, KDAC3, RPD3, RPD3-2}, DLK1 (delta like non-canonical Notch ligand 1) [NCBI Gene 8788] {aka DLK, DLK-1, Delta1, FA1, PREF1, Pref-1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581] {aka CP7A, CYP7, CYPVII}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050] {aka C/EBP-alpha, CEBP}, ATHS (atherosclerosis susceptibility (lipoprotein associated)) [NCBI Gene 470] {aka ALP}, NOD1 (nucleotide binding oligomerization domain containing 1) [NCBI Gene 10392] {aka CARD4, CLR7.1, NLRC1, hNod1}, ADIPOR1 (adiponectin receptor 1) [NCBI Gene 51094] {aka ACDCR1, CGI-45, CGI45, PAQR1, TESBP1A}, MIR33A (microRNA 33a) [NCBI Gene 407039] {aka MIR33, MIRN33, MIRN33A, hsa-mir-33, hsa-mir-33a, miR-33}, IRS2 (insulin receptor substrate 2) [NCBI Gene 8660] {aka IRS-2}, HNMT (histamine N-methyltransferase) [NCBI Gene 3176] {aka HMT, HNMT-S1, HNMT-S2, MRT51}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, MIR10A (microRNA 10a) [NCBI Gene 406902] {aka MIRN10A, hsa-mir-10a, miRNA10A, mir-10a}, POMC [NCBI Gene 100540012], GNRH1 (gonadotropin releasing hormone 1) [NCBI Gene 2796] {aka GNRH, GRH, LHRH, LNRH}, APPL1 (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) [NCBI Gene 26060] {aka APPL, DIP13alpha, MODY14}, NPY (neuropeptide Y) [NCBI Gene 4852] {aka PYY4}, MAP2K4 (mitogen-activated protein kinase kinase 4) [NCBI Gene 6416] {aka JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, GPBAR1 (G protein-coupled bile acid receptor 1) [NCBI Gene 151306] {aka BG37, GPCR19, GPR131, M-BAR, TGR5}, LEPR [NCBI Gene 100125334], INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CETP (cholesteryl ester transfer protein) [NCBI Gene 1071] {aka BPIFF, HDLCQ10}, CD36 (CD36 molecule (CD36 blood group)) [NCBI Gene 948] {aka BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV}, MIR122 (microRNA 122) [NCBI Gene 406906] {aka MIR122A, MIRN122, MIRN122A, hsa-mir-122, miRNA122, miRNA122A}, TRPV1 (transient receptor potential cation channel subfamily V member 1) [NCBI Gene 7442] {aka VR1}, KDM1A (lysine demethylase 1A) [NCBI Gene 23028] {aka AIMAH3, AOF2, BHC110, CPRF, KDM1, LSD1}, SLC2A4 (solute carrier family 2 member 4) [NCBI Gene 6517] {aka GLUT4}, IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, ANK1 (ankyrin 1) [NCBI Gene 286] {aka ANK, SPH1, SPH2, ankyrin-1}, LEP [NCBI Gene 723982], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, SREBF1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 6720] {aka HMD, IFAP2, SREBP1, bHLHd1}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, HIF3A (hypoxia inducible factor 3 subunit alpha) [NCBI Gene 64344] {aka HIF-3A, HIF3-alpha-1, IPAS, MOP7, PASD7, bHLHe17}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, KLK15 (kallikrein related peptidase 15) [NCBI Gene 55554] {aka ACO, HSRNASPH}, UCP1 (uncoupling protein 1) [NCBI Gene 7350] {aka SLC25A7, UCP}, TXNIP (thioredoxin interacting protein) [NCBI Gene 10628] {aka ARRDC6, EST01027, HHCPA78, THIF, VDUP1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}
- **Diseases:** MetS (MESH:D024821), hyperglycemia (MESH:D006943), liver disease (MESH:D008107), Chronic inflammation (MESH:D007249), Zucker fatty (MESH:D008067), injury to (MESH:D014947), neurodegeneration (MESH:D019636), impaired mitochondrial function (MESH:D028361), atherogenic (MESH:D050197), coronary heart disease (MESH:D003327), impaired glucose and lipid metabolism (MESH:D052439), impaired glucose regulation (MESH:C565631), POMC deficiency (MESH:D007153), nutritional deficiencies (MESH:D044342), hypertension (MESH:D006973), PCOS (MESH:D011085), blood (MESH:D006402), cancer (MESH:D009369), FGIDs (MESH:D005767), Diabetes (MESH:D003920), endothelial dysfunction (MESH:D014652), LEPR deficiency (OMIM:614963), Dysbiosis (MESH:D064806), hypoglycemia (MESH:D007003), leptin resistance (OMIM:614962), CVD (MESH:D002318), NAFLD (MESH:D065626), myocardial infarction (MESH:D009203), neuroinflammation (MESH:D000090862), IR (MESH:D007333), anxiety (MESH:D001007), postpartum depression (MESH:D019052), osteoporosis (MESH:D010024), toxicity (MESH:D064420), metabolic, neurocognitive, and psychological disorders (MESH:D000067073), vascular injury (MESH:D057772), depressive symptoms (MESH:D003866), Obesity (MESH:D009765), Excess adiposity (MESH:D018205), inflammatory bowel disease (MESH:D015212), autoimmune disease (MESH:D001327), gestational diabetes mellitus (MESH:D016640), metabolic and hormonal disorders (MESH:C566454), weight gain (MESH:D015430), fatty liver disease (MESH:D005234), type 2 diabetes (MESH:D003924), NCCDs (MESH:D000073296), unhealthy eating behaviours (MESH:D001068), allergies (MESH:D004342), Chronic low (MESH:D009800), T1D (MESH:D003922), Overweight (MESH:D050177), reduced muscle and bone mass (MESH:D009135), cardiac remodelling (MESH:D020257), hyperhomocysteinemia (MESH:D020138), neglect (MESH:D058069), B12 deficiency (MESH:D014806), cardiomyopathy (MESH:D009202), Cushing's (MESH:D003480), neurological and oncological disorders (MESH:D000072716)
- **Chemicals:** vitamin D (MESH:D014807), VA (MESH:C038780), MC1568 (MESH:C577554), bile acid (MESH:D001647), Curcumin (MESH:D003474), palmitate (MESH:D010168), EGCG (MESH:C045651), succinate (MESH:D019802), B6 (-), methionine (MESH:D008715), betaine (MESH:D001622), sodium (MESH:D012964), oxygen (MESH:D010100), pyridoxine (MESH:D011736), carnitine (MESH:D002331), TMAO (MESH:C005855), Pi (MESH:D010716), alpha-ketoglutarate (MESH:D007656), inorganic phosphate (MESH:D010710), acid (MESH:D000143), PUFAs (MESH:D005231), sugar (MESH:D000073893), TG (MESH:D013866), Quercetin (MESH:D011794), amino acids (MESH:D000596), isoflavones (MESH:D007529), homocysteine (MESH:D006710), cortisol (MESH:D006854), choline (MESH:D002794), lignans (MESH:D017705), CpG (MESH:C015772), Omega-3 fatty acids (MESH:D015525), estradiol (MESH:D004958), butyrate (MESH:D002087), S-equol (MESH:D060754), CORT (MESH:D003348), adrenaline (MESH:D004837), oils (MESH:D009821), arginine (MESH:D001120), FAs (MESH:D005227), methylmalonic acid (MESH:D008764), carbohydrate (MESH:D002241), carbon (MESH:D002244), plant sterols (MESH:D010840), MUFAs (MESH:D005229), vitamin B2 (MESH:D012256), starches (MESH:D013213), stilbene (MESH:D013267), corticosterone (MESH:D003345), TFAs (MESH:D014269), propionate (MESH:D011422), simple sugars (MESH:D009005), valproic acid (MESH:D014635), triglyceride (MESH:D014280), SFN (MESH:C016766), steroid (MESH:D013256), omega-6 fatty acids (MESH:D043371), carotenoids (MESH:D002338), phlorizin (MESH:D010695), Capsaicin (MESH:D002211)
- **Species:** Faecalibacterium (genus) [taxon 216851], Bacteroides (genus) [taxon 816], Mediterraneibacter gnavus (species) [taxon 33038], Mus musculus (house mouse, species) [taxon 10090], Prevotella (genus) [taxon 838], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Bifidobacterium (genus) [taxon 1678], Salmonella enterica (species) [taxon 28901], Arachis hypogaea (goober, species) [taxon 3818], Meleagris gallopavo (common turkey, species) [taxon 9103], Anaerostipes (genus) [taxon 207244], gut metagenome (species) [taxon 749906]
- **Mutations:** C677T, DeltaG133 frameshift, P316T, R236G, W646C
- **Cell lines:** C3H10T1/2 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0190)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940604/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940604/full.md

## References

304 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940604/full.md

---
Source: https://tomesphere.com/paper/PMC12940604